AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 230 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,664 | +7.8% | 330,425 | +18.7% | 0.17% | -8.0% |
| Q4 2022 | $3,399 | -99.8% | 278,352 | +28.9% | 0.19% | +38.2% |
| Q3 2022 | $2,254,000 | +306.9% | 215,912 | +318.9% | 0.14% | +223.8% |
| Q2 2022 | $554,000 | -62.2% | 51,548 | -66.7% | 0.04% | -56.2% |
| Q1 2022 | $1,466,000 | +175.0% | 154,799 | +235.6% | 0.10% | +43.3% |
| Q4 2021 | $533,000 | +40.3% | 46,126 | +15.9% | 0.07% | +31.4% |
| Q3 2021 | $380,000 | +104.3% | 39,795 | +106.7% | 0.05% | -19.0% |
| Q2 2021 | $186,000 | -60.1% | 19,254 | -59.1% | 0.06% | -57.7% |
| Q1 2021 | $466,000 | -65.5% | 47,128 | -19.4% | 0.15% | -61.3% |
| Q4 2020 | $1,350,000 | +203.4% | 58,468 | +85.4% | 0.38% | +173.0% |
| Q3 2020 | $445,000 | -61.7% | 31,528 | -59.1% | 0.14% | -64.3% |
| Q2 2020 | $1,162,000 | +27.4% | 77,078 | -21.9% | 0.40% | +2.6% |
| Q1 2020 | $912,000 | – | 98,675 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |